Payment Method and Quittance under Article 3

1. Key takeaways

The formal requirements for fee payment are stated once in each of two texts. Article 3 of Décret exécutif n° 21-551 provides that the redevance must be paid in full by the pharmaceutical establishment into the account of the domiciliary bank (banque domiciliataire) of the ANPP, on the basis of the payment slip (bordereau de versement) issued by the ANPP, with payment evidenced by bank documents. Article 2 of the Ministerial Order of 10 May 2021 and Article 21 of Executive Decree n° 20-324, for their part, require the payment voucher to be submitted with the dossier and a receipt to be obtained. The judgement of GRZAN: the voucher is not an annex, it is an admissibility requirement.

This distinction matters operationally. A dossier that is technically complete but travels without its payment proof is not a slightly weaker dossier; it is an unadmissible one. The payment sequence — slip, bank, voucher, receipt — must therefore be planned into the submission calendar with the same seriousness as the technical file itself.

2. Legal basis

1. Décret exécutif n° 21-551 du 25 Joumada El Oula 1443 correspondant au 30 décembre 2021 fixant les modalités de recouvrement et d’affectation du produit de la redevance des produits pharmaceutiques et des dispositifs médicaux (Executive Decree No. 21-551 of 30 December 2021 on the collection and allocation of the redevance on pharmaceutical products and medical devices, JORADP No. 02, published 5 January 2022, pages 14–15): Article 3 (payment in full into the account of the ANPP domiciliary bank, on the basis of the payment slip, evidenced by bank documents), Article 4 (the ANPP remits 70 percent).
2. Décret exécutif n° 21-552 du 25 Joumada El Oula 1443 correspondant au 30 décembre 2021 fixant les modalités d’acquittement et d’affectation du produit de la taxe de contrôle et expertise de lot de produit pharmaceutique et/ou de dispositif médical (Executive Decree No. 21-552 of 30 December 2021 on the payment and allocation of the batch control and expertise tax on pharmaceutical products and/or medical devices, JORADP No. 02, published 5 January 2022, pages 15–16): Article 3 (the control tax is likewise paid in full into the account of the ANPP domiciliary bank, on the basis of the payment slip).
3. Arrêté du 28 Ramadhan 1442 correspondant au 10 mai 2021 fixant la composition du dossier d’homologation et du dossier de renouvellement de la décision d’homologation des dispositifs médicaux à usage de la médecine humaine (Ministerial Order of 10 May 2021 on the composition of the homologation dossier and the renewal dossier of the homologation decision for medical devices for human medicine, JORADP No. 55, published 14 July 2021, pages 21–24, 13 articles in total): Article 2 (fees must be paid upon submission, voucher submitted with the dossier), Article 3 (submission by the pharmacien directeur technique).
4. Décret exécutif n° 20-324 du 6 Rabie Ethani 1442 correspondant au 22 novembre 2020 relatif aux modalités d’homologation des dispositifs médicaux (Executive Decree No. 20-324 of 22 November 2020 on the procedures for homologation of medical devices, JORADP No. 69, published 22 November 2020, pages 10–14, 46 articles in total): Article 21 (payment and receipt), Article 22 (the admissibility review verifies payment of the fees).

3. Expert insights

Insight 1: the payment slip is issued by the ANPP, not drafted by the company. The wording of Article 3 is payment sur la base d’un bordereau de versement établi par les services de l’agence, on the basis of a payment slip established by the services of the agency. The sequence is therefore: apply to the ANPP for the payment slip, take it to the bank to pay, and return the bank documents to the ANPP. A company cannot estimate the amount itself and remit it directly; a self-calculated transfer has no regulatory value and creates reconciliation problems that delay admissibility.

Insight 2: Article 22 lists payment of the fees as one of the three objects of the admissibility review. Article 22 of Executive Decree No. 20-324 provides that the admissibility review verifies the completeness of the dossier, the authenticity of the documents, and payment of the fees. The three are placed side by side. This means a missing payment voucher leads directly to rejection of the dossier — it is a problem of the same rank as incomplete technical documentation, not a curable formality to be fixed during substantive review.

Insight 3: the receipt (récépissé) is the crossover point of the payment and submission actions. Article 21 provides that after payment the ANPP issues a receipt; Article 2 of the Ministerial Order of 2021 and Article 5 of the regularisation Ministerial Order contain the same requirement. The date recorded on the receipt serves both as the reference for completed payment and as the reference for the start of admissibility. It must be requested and checked on the spot, because a wrong date on the receipt silently shifts every downstream deadline in the project calendar.

Insight 4: the payment route for both charges is identical, but their allocation accounts differ. Article 3 of Executive Decree No. 21-551 and Article 3 of Executive Decree No. 21-552 use almost identical wording (both require payment in full into the account of the ANPP domiciliary bank, on the basis of the payment slip, evidenced by bank documents). The difference lies in the subsequent allocation: the redevance is 70 percent into the special fund and 30 percent to the ANPP; the control tax is 50 percent remitted to the treasury. For the company the operation is the same, but the accounting must be kept separate.

4. Practical recommendations

1. Before submission, apply to the ANPP for the payment slip and pay the exact amount stated on it; do not self-estimate.
2. After payment, obtain the original bank documents and scan them into the archive; they are the proof of payment required by Article 3.
3. Submit the payment voucher with the dossier and list it in the checklist on the first page of the file.
4. Request the receipt on the spot and verify its date; treat the receipt date as day 0 of the project.
5. Keep the redevance and the control tax in separate accounts, matching the 70 percent and 50 percent allocations.
6. Maintain a register of all payment records, linked to the certificate register.

5. Verification checklist

• □ The payment slip has been requested from the ANPP and the amount stated on it paid.
• □ The original bank documents have been obtained and scanned into the archive.
• □ The payment voucher has been submitted with the dossier and listed in the first-page checklist.
• □ The receipt has been requested on the spot, its date verified and set as day 0.
• □ The redevance and the control tax are kept in separate accounts.
• □ A payment register is in place and linked to the certificate register.

Further reading in this series: Fee anchors: modification 150,000, renewal 300,000, transfer 100,000 dinars — https://www.grzanglobal.com/algeria-medical-device-registration/fee-anchors-modification-renewal-transfer/ ; The batch control tax: what 30,000, 60,000 and 24,000 dinars each correspond to — https://www.grzanglobal.com/algeria-medical-device-registration/batch-control-tax-dmd-amounts/ ; The 8-day admissibility review: what Article 22 of Executive Decree 20-324 examines — https://www.grzanglobal.com/algeria-medical-device-registration/article-22-admissibility-review-eight-days/

Regulatory information verified as of 30 October 2026.

GRZAN supports medical device manufacturers entering Algeria with the appointment of a qualified local authorised representative and importer, execution of the payment and quittance route of Article 3 of Executive Decree n° 21-551, and complete fee budgeting in Algerian dinars (DZD). For assistance with payment documentation or any question on this topic, contact info@grzanglobal.com.